Mount Sinai Hospital Medical Center ( Site 0032) — Chicago, Illinois

Mount Sinai Hospital Medical Center ( Site 0032) is a clinical research site located in Chicago, Illinois, United States 60608.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Hospital Medical Center ( Site 0032) has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Nonsquamous Non-small-cell Lung.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Hospital Medical Center ( Site 0032)?

Mount Sinai Hospital Medical Center ( Site 0032) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Hospital Medical Center ( Site 0032) conducted?

Mount Sinai Hospital Medical Center ( Site 0032) has 1 clinical trials on record. Their work covers Carcinoma, Nonsquamous Non-small-cell Lung.

Is Mount Sinai Hospital Medical Center ( Site 0032) accredited by Crixeo Health?

Mount Sinai Hospital Medical Center ( Site 0032) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Hospital Medical Center ( Site 0032)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.